In mid-January 2026, Bernstein upgraded Vertex Pharmaceuticals to Outperform and UBS initiated coverage with a Buy rating, both citing confidence in the company’s core cystic fibrosis business and ...

The latest change in the price target for Canadian Imperial Bank of Commerce has put fresh attention on what investors should expect from the stock and why the narrative is shifting now. With analysts ...

California lawmakers and finance officials on Wednesday talked over how best to resolve a budget deficit totaling billions of ...

The US Treasury secretary said Christian Sewing had called him to distance the bank from one of his analyst’s reports ...

For decades, Baby Boomer–era brands dominated American kitchens, lunchboxes, and pantries. These companies thrived on brand ...

The auto lender's earnings mostly surpassed expectations in the fourth quarter, but in 2026 it expects higher unemployment ...

The Army’s Joint Program Executive Office Armaments and Ammunition (JPEO A&A) is celebrating the success of its direct-hire ...

The futures are trading lower again after a dreadful risk-off day across Wall Street, where all major indices finished the day solidly lower. The combination of President Trump’s pursuit of Greenland, ...

On the earnings call, Netflix co-CEO Ted Sarandos revealed his thinking behind the splashy $72 billion deal for Warner Bros.

Several California lawmakers on Tuesday signaled they're concerned Gov. Gavin Newsom wants to wait until May to sort out some of the state's biggest money issues. The problem was front and center in ...

Discover which investment banks are leading the energy sector, uncover insights on top players like JPMorgan and Citigroup, ...

Business performance aside, an analyst at RBC Capital has set Palantir's share price target at $50, a 70% drop from its ...